Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cost effectiveness analysis of immunotherapy regimens currently approved in advanced or recurrent endometrial cancer: An analysis of the NRG-GY 018, RUBY, and DUO-E trials.
Francoeur AA, Liang SY, File B, Choi E, Brameld M, Richardson MT, Johnson CR, Kapp DS, Tewari KS, Chan JK. Francoeur AA, et al. Gynecol Oncol Rep. 2026 Feb 18;64:102050. doi: 10.1016/j.gore.2026.102050. eCollection 2026 Apr. Gynecol Oncol Rep. 2026. PMID: 41767212 Free PMC article.
METHODS: Partitioned survival models were established based on the RUBY, NRG-GY 018, and DUO-E trials, as well as available FDA data. Incremental cost-effectiveness ratios (ICERs) were estimated based on quality adjusted progression free life years saved (QA-PFLYS). ...
METHODS: Partitioned survival models were established based on the RUBY, NRG-GY 018, and DUO-E trials, as well as available FDA data. …
Major Advances in Gynecologic Oncology in 2025: Systematic Review and Synthesis of Conference and Published Evidence.
Ismaili N. Ismaili N. Biomedicines. 2026 Jan 28;14(2):295. doi: 10.3390/biomedicines14020295. Biomedicines. 2026. PMID: 41751194 Free PMC article. Review.
Novel therapeutic mechanisms, including glucocorticoid receptor modulation (ROSELLA trial) and cadherin-6-targeted antibody-drug conjugates (REJOICE-Ovarian01), showed remarkable efficacy. (3) In endometrial cancer, updated analyses from NRG GY018 and RUBY trials solidifie …
Novel therapeutic mechanisms, including glucocorticoid receptor modulation (ROSELLA trial) and cadherin-6-targeted antibody-drug conjugates …
Visualizing application of RUBY-MAT system in maize genetic transformation and gene expression pattern detection.
Jia T, Zhao S, Zhang X, Li Y, Cheng K, Qian X, Song M, Ge W, Liu Q, Xu H, Li F, Hu J, Hao Q, Tian Y, Li B. Jia T, et al. Plant Cell Rep. 2026 Feb 26;45(3):66. doi: 10.1007/s00299-026-03749-1. Plant Cell Rep. 2026. PMID: 41746379
RUBY-MAT system, integrating the RUBY reporter and MAT module, was innovatively applied to Agrobacterium-mediated maize transformation, and precise spatiotemporal gene expression analysis. ...Experimental results demonstrated that RUBY-MAT system can be succe …
RUBY-MAT system, integrating the RUBY reporter and MAT module, was innovatively applied to Agrobacterium-mediated maize transf …
5,301 results